Cite
Assessment of myocardial perfusion-CMR in left main stem disease (LMS) in the CEMARC study
MLA
John F. Younger, et al. “Assessment of Myocardial Perfusion-CMR in Left Main Stem Disease (LMS) in the CEMARC Study.” Journal of Cardiovascular Magnetic Resonance, vol. 13, no. Suppl 1, p. P170. EBSCOhost, https://doi.org/10.1186/1532-429x-13-s1-p170. Accessed 22 Sept. 2024.
APA
John F. Younger, Catherine J Dickinson, Aleksandra Radjenovic, David L. Buckley, Neil Maredia, Jane Nixon, Sven Plein, John P. Ridgway, Arshad Zaman, Steven G Ball, Steven Sourbron, Colin C Everett, Julia Brown, John P Greenwood, & Mark Sculpher. (n.d.). Assessment of myocardial perfusion-CMR in left main stem disease (LMS) in the CEMARC study. Journal of Cardiovascular Magnetic Resonance, 13(Suppl 1), P170. https://doi.org/10.1186/1532-429x-13-s1-p170
Chicago
John F. Younger, Catherine J Dickinson, Aleksandra Radjenovic, David L. Buckley, Neil Maredia, Jane Nixon, Sven Plein, et al. 2024. “Assessment of Myocardial Perfusion-CMR in Left Main Stem Disease (LMS) in the CEMARC Study.” Journal of Cardiovascular Magnetic Resonance 13 (Suppl 1): P170. Accessed September 22. doi:10.1186/1532-429x-13-s1-p170.